| Date Filed | Type | Description |
| 06/26/2020 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 12/26/2018 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/24/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/13/2018 |
4
| ROGERS MICHAEL W (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 30,000 shares
@ $0
Disposed/sold 140,000 options
@ $0 |
|
| 12/13/2018 |
4
| Enyedy Mark J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 10,000 shares
@ $0
Disposed/sold 80,000 options
@ $0 |
|
| 12/13/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 162,956 shares
@ $0
Disposed/sold 902,500 options
@ $0 |
|
| 12/13/2018 |
4
| Morrison Jodie Pope (Interim CEO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 120,000 shares
@ $0
Disposed/sold 110,000 options
@ $0 |
|
| 12/13/2018 |
4
| Regan Daniel Paul (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 60,000 shares
@ $0
Disposed/sold 200,000 options
@ $0 |
|
| 12/13/2018 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 20,000 shares
@ $0
Disposed/sold 110,000 options
@ $0 |
|
| 12/13/2018 |
4
| GILMAN STEVEN C (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 27,333 shares
@ $0
Disposed/sold 140,000 options
@ $0 |
|
| 12/13/2018 |
4
| Neylan John F. (Chief Medical Officer) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 148,279 shares
@ $0
Disposed/sold 772,500 options
@ $0 |
|
| 12/13/2018 |
4
| Cameron Kevin J (Director) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 186,666 shares
@ $0
Disposed/sold 290,000 options
@ $0 |
|
| 12/13/2018 |
4
| Carberry Christine A. (COO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 10,469 shares
@ $3.22, valued at
$33.7k
Disposed/sold 100,646 shares
@ $0
Disposed/sold 422,500 options
@ $0 |
|
| 12/13/2018 |
4
| BAUPOST GROUP LLC/MA (10% Owner) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 35,582,335 shares
@ $4.63, valued at
$164.7M
Granted 4,000,000 shares
@ $0
Disposed/sold 65,374,013 shares
@ $0
Exercised options to buy
@ $4.63, valued at
$0 |
|
| 12/13/2018 |
SC 13D/A
| Baupost Group reports a 0% stake in Keryx Biopharmaceuticals, Inc. |
| 12/13/2018 |
POS462B
| Form POS462B - Post-effective amendment to registration statement [Rule 462(b)]: |
| 12/13/2018 |
POS462B
| Form POS462B - Post-effective amendment to registration statement [Rule 462(b)]: |
| 12/13/2018 |
POS462B
| Form POS462B - Post-effective amendment to registration statement [Rule 462(b)]: |
| 12/13/2018 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 12/13/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
|